Interaction between complement proteins C5b-7 and erythrocyte membrane sialic acid

Journal of Experimental Medicine

Volumn 184, Issue 4, 1996, Pages 1225-1232

  Marshall, Patricia ^a   Hasegawa, Akira ^c   Davidson, Eugene A ^b   Nussenzweig, Victor ^d   Whitlow, Michael ^a,b,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c GIFU UNIVERSITY   (Japan)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID; COMPLEMENT COMPONENT C5B; GANGLIOTETRAOSYLCERAMIDE; GLYCOPHORIN; SIALIC ACID;

ARTICLE; CELL INTERACTION; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; EUKARYOTE; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPID COMPOSITION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ASIALOGLYCOPROTEINS; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, AFFINITY; COMPLEMENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; ERYTHROCYTE MEMBRANE; G(M3) GANGLIOSIDE; GANGLIOSIDES; GLYCOPHORIN; GUINEA PIGS; HEMOLYSIS; HUMANS; MOLECULAR SEQUENCE DATA; N-ACETYLNEURAMINIC ACID; TRYPSIN;

EID: 0029904802     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.4.1225     Document Type: Article

References (45)

1. Mayer, M. 1978. Complement, past and present. Harvey Lect. 72:139-193.
2. Mayer, M.M., D.W. Michaels, L.E. Ramm, M.B. Whitlow, J.B. Willoughby, and M.L. Shin. 1981. Membrane damage by complement. Crit. Rev. Immunol. 2:133-165.
3. Esser, A.F. 1994. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 87:229-247.
4. Hammer, C.H., A. Nicholson, and M.M. Mayer. 1975. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes. Proc. Natl. Acad. Sci. USA. 72:5076-5080.
5. Hammer, C.H., M.L. Shin, A.S. Abramovitz, and M.M. Mayer. 1977. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes. J. Immunol. 119:1-8.
6. Iida, K., M.B. Whitlow, and V. Nussenzweig. 1991. Membrane vesiculation protects erythrocytes from destruction by complement. J. Immunol. 147:2638-2642.
7. Preissner, K.T. 1989. The role of vitronectin as multifunctional regulator in the hemostatic and immune systems. Blut. 59:419-431.
8. Jenne, D.E. and J. Tschopp. 1992. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem. Sci. 17:154-159.
9. Goldlust, M.B., H.S. Shin, C.H. Hammer, and M.M. Mayer. 1974. Studies of complement complex C5b,6 eluted from EAC1-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5. J. Immunol. 113:998-1007.
10. Hu, V.W., A.F. Esser, E.R. Podack, and B.J. Wisnieski. 1981. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane. J. Immunol. 127:380-386.
11. Hammer, C.H., A.S. Abramovitz, and M.M. Mayer. 1976. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components. J. Immunol. 117:830-834.
12. Silversmith, R.E., and G.L. Nelsestuen. 1986. Interaction of complement proteins C5b-6 and C5b-7 with phospholipid vesicles: effects of phospholipid structural features. Biochemistry. 25:7717-7725.
13. Tschopp, J., and D. Masson. 1987. Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans. Mol. Immunol. 24:907-913.
14. Baker, P.J., T.F. Lint, B.C. McLeod, C.L. Behrends, and H. Gewurz. 1975. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis by polyanions and polycations. J. Immunol. 114:554-558.
15. Vargas, F.F. 1994. Electrical surface phenomenon of endothelial cells. In Cell Electrophoresis. J. Bauer, editor. CRC Press, Boca Raton, FL. 241-253.
16. Warren, L. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975.
17. Yamamoto, K., and H. Gewurz. 1978. The complex of C5b and C6: isolation, characterization and identification of a modified form of C5b consisting of three polypeptide chains. J. Immunol. 120:2008-2015.
18. Whitlow, M.B., I. Stefanova, A. Bernard, and V. Nussenzweig. 1990. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement. Cell. Immunol. 133:3235-3241.
19. 18a. Mishell, B.B., and S.M. Shiigi. 1980. Preparation of active antibody fragments. In Selected Methods in Cellular Immunology. B.B. Mishell and S.M. Shiigi, editors. W H Freeman and Company. 284-286.
20. Su, S., R.S. Ashok, I. Ekwere, and E.A. Davidson. 1993. A monoclonal antibody capable of blocking the binding of PF200(MSA-1) to human erythrocytes and inhibiting the invasion of Plasmodium falciparum merozoites into human erythrocytes. J. Immunol. 151:2309-2317.
21. 3. Carbohydr. Res. 188:71-80.
22. 3 position isomer, N-acetylneuraminosyl(α2-6)lactosyl(β1-1)ceramide. Biosci. Biotech. Biochem. 56:535-536.
23. 3 analogs containing the chemically modified sialic acids. J. Carbohydr. Chem. 11:95-116.
24. 3 analogs containing a deoxy-N-acetylneuraminic acid residue. J. Carbohydr. Chem. 230:273-288.
25. Yoshida, M., H. Ishida, M. Kiso, and A. Hasegawa. 1996. Synthesis of N-acetyl-4-8-dideoxyneuraminic acid-containing ganglioside GM3. Carbohydr. Res. 280:331-338.
26. Murase, T., A. Kameyama, K.P.R. Kartha, H. Ishida, M. Kiso, and A. Hasegawa. 1989. Synthetic studies on sialoglycoconjugates. V. A facile, regio and stereoselective synthesis of ganglioside GM4 and its position isomer. J. Carbohydr. Chem. 8:265-283.
27. Hasegawa, A., N. Suzuki, F. Kozawa, H. Ishida, and M. Kiso. 1996. J. Carbohydr. Chem. In press.
28. Terada, T., M. Kiso, and A. Hasegawa. 1993. Synthetic studies on sialoglycoconjugates. 44. Synthesis of KDN-gangliosides GM4 and GM3. J. Carbohydr. Chem. 12:425-440.
29. Hasegawa, A., K. Adachi, M. Yoshida, and M. Kiso. 1992. Synthetic studies on siloglycoconjugates. 32. Synthesis of a ganglioside GM3 analog containing a hydroxymethyl group in place of the carboxyl group in the N-acetylneuraminic acid unit. Biosci. Biotech. Biochem. 56:445-447.
30. Perkins, M. 1981. Inhibitory effects of erythrocyte membrane proteins on the in vitro invasion of the human malarial parasite (Plasmodium falciparum) into its host cell. J. Cell Biol. 90: 563-567.
31. Ollert, M.W., K. David, R. Bredehorst, and C.-W. Vogel. 1995. Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b. J. Immunol. 155:4955-4962.
32. Michalek, M. T., C. Mold, and E. G. Bremer. 1988. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid. J. Immunol. 140:1588-1594.
33. Pangburn, M. K., M. A. Atkinson, and S. Meri. 1991. Localization of the heparin-binding site on complement factor H. J. Biol. Chem. 266:16847-16853.
34. Haefliger, J., J. Tschopp, N. Vial, and D.E. Jenne. 1989. Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6. J. Biol. Chem. 264:18041-18051.
35. Smith, K. F., K. F. Nolan, K. B. M. Reid, and S. J. Perkins. 1991. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat. Biochemistry. 30:8000-8008.
36. Holt, G.D., M.K. Pangburn, and V. Ginsburg. 1990. Properdin binds to sulfatide and has a sequence homology with other proteins that bind sulfated glycoconjugates. J. Biol. Chem. 265:2852-2855.
37. Holt, G.D., H.C. Krivan, G.J. Gasic, and V. Ginsburg. 1989. Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide and has a sequence homology with other proteins that bind sulfated glycoconjugates. J. Biol. Chem. 264:12138-12140.
38. Sahu, A., and M. K. Pangburn. 1993. Identification of multiple sites of interaction between heparin and the complement system. Molec. Immunol. 30:679-684.
39. DiScipio, R. G., D. N. Chakavarti, H. J. Muller-Eberhard, and G. H. Fey. 1988. The structure of human complement component C7 and the C5b-7 complex. J. Biol. Chem. 263: 549-560.
40. Podack, E.R., W. Stoffel, A.F. Esser, and H.J. Muller-Eberhard. 1981. Membrane attack complex of complement: distribution of subunits between the hydrocarbon phase of target membranes and water. Proc. Natl. Acad. Sci. USA. 78: 4544-4548.
41. Tomita, A., E. Radike, and C. J. Parker. 1995. Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A. J. Immunol. 151:3308-3323.
42. Varki, A. 1994. Selectin ligands. Proc. Natl. Acad. Sci. USA. 91:7390-7397.
43. Akami, T., M. Arakawa, M. Okamoto, K. Akioka, I. Fujiwara, I. Nakai, M. Mitsuo, R. Sawada, M. Naruto, and T. Oka. 1994. Enhancement of the complement regulatory function of CD59 by site-directed mutagenesis at the N-glycosylation site. Transplant. Proc. 26:1256-1258.
44. Ninomiya, H., B.H. Stewart, S.A. Rollins, J. Zhao, A.L.M. Bothwell, and P. Sims. 1992. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J. Biol. Chem. 267:8401-8404.
45. Magee, J. C., and J.L. Platt. 1994. Xenograft rejection : molecular mechanisms and therapeutic implications. Ther. Immunol. 1:45-58.